New AI Foundation Model Predicts Drug-Protein Interactions and Designs Novel Therapeutics
Two independent research groups have published AI-driven frameworks for protein and drug design: SurfDesign, which uses molecular surface geometry to guide protein engineering, and dtSFM, a foundation model that predicts drug-target binding specificity directly from sequence using thermodynamic principles. SurfDesign outperforms prior methods on binder and enzyme design benchmarks, while dtSFM demonstrates high recall in identifying drug targets and generates novel drug candidates validated by AlphaFold 3 structural checks. Both advances could accelerate the discovery of new therapeutics, though neither has yet undergone experimental wet-lab validation.
SurfDesign, presented as a KDD 2026 AI4Science submission, introduces a protein design framework that treats molecular surfaces as continuous geometric manifolds rather than relying solely on backbone structure. It uses surface-based equivariant message passing to capture curvature, surface normals, and directional geometry, combined with parameter-efficient fine-tuning of pretrained protein language models, and outperforms existing surface-conditioned and backbone-only methods on de novo binder and enzyme design benchmarks. Separately, the drug-target Specificity Foundation Model (dtSFM), posted to bioRxiv, exploits a mathematical equivalence between transformer softmax attention and the Boltzmann distribution to compute drug-protein binding compatibility as a thermodynamic quantity directly from molecular sequences, without requiring 3D structure prediction as a prerequisite. Trained on over 714,000 measured drug-protein interactions, dtSFM achieves 95% and 89% recall-at-10 for retrieving a drug's target and a target's drug, respectively, and ranks known off-targets of clinical kinase inhibitors in the top 0.6% of a proteome-scale screen. Its generative decoder produced 1,200 novel drug candidates across 16 targets, with 71% matching the structural confidence of approved drugs as assessed by AlphaFold 3. Both studies represent sequence- and geometry-native approaches to a longstanding challenge in computational biology, but experimental validation remains the critical outstanding step for both frameworks.
What's missing
Neither study has reported experimental wet-lab validation of its designed molecules or binders; dtSFM explicitly flags this as the immediate next step. For SurfDesign, benchmark comparisons are computational, and independent replication on real-world therapeutic targets has not been reported. For dtSFM, the training data is limited to publicly available interaction measurements, which may underrepresent rare or understudied protein families, and the use of AlphaFold 3 as a structural verifier—while orthogonal in architecture—does not substitute for empirical binding assays.
What different sources said
- arXiv q-bioCenter
FoldSAE: Learning to Steer Protein Folding Through Sparse Representations
- bioRxivCenter
Promera: a unified model for biomolecular structure prediction, filtering, and design
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.